Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalCombined Modality TherapyLymphomaBone Marrow TransplantationLymphoma, Non-HodgkinGraft SurvivalCyclophosphamideHematopoietic Stem CellsBusulfanTreatment OutcomeMyeloablative AgonistsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsStem CellsCord Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceTissue DonorsRemission InductionAntineoplastic Agents, AlkylatingEtoposideHistocompatibilityPOEMS SyndromeThiotepaWhole-Body IrradiationLymphoma, T-CellDisease-Free SurvivalHistocompatibility TestingInfectionTransplantation, IsogeneicRetrospective StudiesVidarabineImmunosuppressive AgentsHodgkin DiseaseVincristineAmyloidosisLeukemiaHematopoiesisSalvage TherapySurvival RateIfosfamideSurvival AnalysisCarmustineCytarabineBlood CellsGraft vs Leukemia EffectTime FactorsLeukemia, Myeloid, AcutePlatelet CountLymphoma, B-CellMyelodysplastic SyndromesCytomegalovirus InfectionsAnemia, AplasticBlood Cell CountFatal OutcomeCytophagocytosisLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeoplasmsLymphocyte DepletionDoxorubicinFollow-Up StudiesImmunophenotypingFeasibility StudiesHistiocytosis, Non-Langerhans-CellLivedo ReticularisOpportunistic InfectionsHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaBone MarrowPrednisoneCyclosporineHLA AntigensBlood DonorsImmunosuppressionProspective StudiesRecombinant ProteinsMesenchymal Stem Cell TransplantationBone Marrow PurgingPrognosisPilot ProjectsLymphoma, Large B-Cell, DiffuseLymphoma, FollicularAntineoplastic AgentsBone Marrow DiseasesAntigens, CDCarboplatin